UNIVERSITY OF ZIMBABWE

Multinational Pharmacogenomics Study in Africa Aims to Optimize Treatment Outcomes

8 months ago

• Professor Collen Masimirembwa leads a multinational study across Nigeria, Kenya, Zimbabwe, and South Africa to explore how genes affect medication response. • The iPROTECTA protocol will test the clinical benefit of pharmacogenomics, using the GenoPharm genetic test to optimize treatments for sickle cell disease and gastro-intestinal tumors. • The study aims to address the gap in pharmacogenomics research and clinical implementation in the Global South, potentially improving treatment outcomes. • The African Institute of Biomedical Science and Technology (AiBST) contributes to genomics training and research, fostering drug development by African scientists.